港股收评：恒指缩量调整跌1.12%，影视股、内银股、餐饮股等逆势走强

Market Overview - The Hong Kong stock market continued its downward trend, with the Hang Seng Index falling 1.12% to stay above the 25,000-point mark, while the Hang Seng China Enterprises Index dropped 1.25% and the Hang Seng Tech Index fell 1.85% [1] Technology Sector - Major technology stocks mostly declined, with Alibaba down over 3%, Kuaishou and Xiaomi Group down over 2%, and Tencent Holdings down 1%. Meituan saw a slight increase, while Baidu rose over 2% [2] Semiconductor Sector - Semiconductor and chip stocks experienced significant declines, with Jingmen Semiconductor and Innodisk down over 7%. Other companies like SMIC, Shanghai Fudan, Huahong Semiconductor, and China Electronics Technology also followed suit [3] Oil Sector - Oil stocks fell, with China Petroleum & Chemical Corporation, China National Petroleum Corporation, and CNOOC down over 1%. Analysts expect OPEC+ to consider increasing production targets in their upcoming meeting, contributing to the decline in oil prices [4] Gold Sector - Gold stocks saw a sharp decline, with Tongguan Gold down nearly 9%. The spot gold market has been volatile, with prices dropping 0.27% to below $3,550 per ounce, indicating a potential technical correction after recent highs [5] Entertainment Sector - The film and entertainment sector showed strength, with Orange Sky Golden Harvest rising over 7%. The summer box office exceeded 11.9 billion yuan, with over 320 million attendees, surpassing last year's figures [6] Coal Sector - Coal stocks were active, with Jiutai Bangda Energy up 4%. Analysts predict that coal prices have reached a low point, and profitability for coal companies is likely to rebound, with potential for price increases by year-end [7] Banking Sector - Banking stocks rose, with Agricultural Bank of China up over 2%. Other banks like China Everbright Bank, Bank of Communications, and Postal Savings Bank also saw gains [8] Individual Stock Movement - Zai Lab saw a significant drop of nearly 12%, closing at 23.04 HKD, with a total market capitalization of 25.75 billion HKD. Recent clinical trial results showed a reduction in previously observed survival benefits for a cancer treatment [9] Capital Flow - Southbound funds recorded a net inflow of 706 million HKD, with the Shanghai-Hong Kong Stock Connect seeing a net inflow of 1.386 billion HKD, while the Shenzhen-Hong Kong Stock Connect had a net outflow of 680 million HKD [10]